Advertisement

Drug Makers Move Toward Over-the-Counter Cialis — Physician’s First Watch

Medical News |
May 29, 2014

Drug Makers Move Toward Over-the-Counter Cialis

By Amy Orciari Herman

Edited by Susan Sadoughi, MD , and Lorenzo Di Francesco, MD, FACP, FHM

The manufacturer of the erectile dysfunction drug tadalafil (Cialis) struck a deal with another drug maker to sell an over-the-counter version of the pill if federal regulators approve, the Wall Street Journal reports.

The manufacturers will need to demonstrate that tadalafil can be used safely and effectively without a prescription. One safety concern: Tadalafil may cause sudden drops in blood pressure when combined with certain heart medications. In addition, if men treat their impotence without seeing a doctor, underlying medical conditions (e.g., diabetes) might go undiagnosed and untreated.

If approved, OTC versions of tadalafil would not hit U.S. and European markets before 2017, when the drug's patents expire.

Reader Comments (2)

Edward M Bednarczyk, PharmD Other Healthcare Professional, Pharmacology/Pharmacy, SUNY at Buffalo

Perhaps its time to revisit the issue of a "behind the counter" class of medications, similar to that in Canada. In practice, this seems to provide at least a modest amount of contact with a health care provider & (hopefully) faster referrals to physicians and fewer serious AE's...

Douglas Gerardi PhD Other Healthcare Professional, Psychiatry, Private Practice

Articles are timely and informative. I utilize information in my daily practice.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement